Could a thyroid hormone boost heart transplant success?

NCT ID NCT06428097

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether giving levothyroxine, a thyroid hormone, right after a heart transplant helps the new heart work better and reduces complications. Adults listed for heart transplant will be randomly assigned to receive levothyroxine or a placebo (saline) during the first hours after surgery. Researchers will measure how much blood pressure support patients need and whether they experience early graft dysfunction, comparing the two groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Levothyroxine, a thyroid hormone, given intravenously after heart transplant surgery
What this could lead to
If it works, this could improve recovery and survival after heart transplant by reducing the need for blood pressure support and lowering the risk of early graft dysfunction.
What could go wrong
This is an early-phase, single-center trial, so results may not apply broadly. Levothyroxine may not improve outcomes and could carry risks, especially in people with thyroid conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.